Heartflow (NASDAQ:HTFL) Shares Up 2.9% – Should You Buy?

Heartflow, Inc. (NASDAQ:HTFL)’s share price traded up 2.9% on Tuesday . The company traded as high as $27.99 and last traded at $27.17. 84,262 shares traded hands during mid-day trading, a decline of 81% from the average session volume of 440,757 shares. The stock had previously closed at $26.40.

Wall Street Analyst Weigh In

Several analysts recently issued reports on the stock. Morgan Stanley initiated coverage on shares of Heartflow in a report on Tuesday, September 2nd. They set an “equal weight” rating and a $35.00 price objective for the company. Zacks Research upgraded shares of Heartflow to a “hold” rating in a report on Wednesday, September 3rd. Piper Sandler began coverage on Heartflow in a research note on Tuesday, September 2nd. They issued an “overweight” rating and a $38.00 price objective on the stock. Stifel Nicolaus increased their target price on Heartflow from $35.00 to $40.00 and gave the company a “buy” rating in a research note on Thursday, November 13th. Finally, Wall Street Zen raised Heartflow to a “hold” rating in a research report on Saturday, August 16th. Four analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $38.60.

Heartflow Price Performance

The firm’s 50 day simple moving average is $34.44.

Heartflow (NASDAQ:HTFL) last announced its quarterly earnings results on Friday, September 19th. The company reported ($1.46) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.20) by ($1.26). The business had revenue of $43.42 million for the quarter, compared to analysts’ expectations of $43.20 million.

Institutional Investors Weigh In On Heartflow

A number of institutional investors have recently added to or reduced their stakes in the stock. Zimmer Partners LP bought a new stake in shares of Heartflow in the 3rd quarter valued at approximately $673,000. Alyeska Investment Group L.P. bought a new stake in Heartflow in the third quarter valued at $2,861,000. Summit Partners Public Asset Management LLC bought a new position in shares of Heartflow during the third quarter valued at $28,559,000. Millennium Management LLC acquired a new stake in shares of Heartflow in the 3rd quarter valued at $3,904,000. Finally, Jain Global LLC acquired a new stake in shares of Heartflow during the 3rd quarter worth about $1,050,000.

Heartflow Company Profile

We have pioneered the use of software and AI to deliver a more accurate and clinically effective non-invasive solution for diagnosing and managing coronary artery disease (“CAD”), a leading cause of death worldwide. As of March 31, 2025, our Heartflow Platform has been used to assess CAD in more than 400,000 patients, including 132,000 in 2024 alone.